Autoantibodies to Nuclear Antigens (ANA): Their Immunobiology and Medicine (Q40104710)

17 September 2017

title

Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine (English)

1 reference

17 September 2017

Autoantibodies to Nuclear Antigens (ANA): Their Immunobiology and Medicine (English)

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60836-6

22 August 2023

1 reference

E. M. Tan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6182766

22 August 2023

publication date

1 January 1982

1 reference

17 September 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6182766

22 August 2023

published in

Advances in Immunology

1 reference

17 September 2017

volume

33

1 reference

17 September 2017

page(s)

167-240

1 reference

publication type of scholarly work

17 September 2017

review article

1 reference

Immunology of DNA. III. Crithidia luciliae, a simple substrate for the determination of anti-dsDNA with the immunofluorescence technique

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Evidence for a subset of rheumatoid factors that cross-react with DNA-histone and have a distinct cross-idiotype

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Antibody to nuclear ribonucleoprotein penetrates live human mononuclear cells through Fc receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Characteristics of antinuclear antibodies in rheumatoid arthritis. Reactivity of rheumatoid factor with a histone-dependent nuclear antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

A soluble acidic protein of the cell nucleus which reacts with serum from patients with systemic lupus erythermatosus and Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Antibodies to cellular antigens in Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Resolution of the identity of certain antigen-antibody systems in systemic lupus erythematosus and sjögren's syndrome: An interlaboratory collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Serum antibody in rheumatoid arthritis reactive with a cell-associated antigen. Demonstration by precipitation and immunofluorescence

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Differentiation and characterization of autoantibodies and their antigens in sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Lymphocytes transformed by Epstein-Barr virus. Induction of nuclear antigen reactive with antibody in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Elevated Levels of Antibodies to Epstein-Barr Virus Antigens in Sera and Synovial Fluids of Patients with Rheumatoid Arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Precipitating Auto-Antibodies in the Connective Tissue Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Localization of fluorescein-labeled antinucleoside antibodies in glomeruli of patients with active systemic lupus erythematosus nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Antibodies to Native and Denatured Deoxyribonucleic Acid in Systemic Lupus Erythematosus*

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Dermatomyositis (systemic angiopathy) of childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Altered regulation of epstein-barr virus induced lymphoblast proliferation in rheumatoid arthritis lymphoid cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Nuclear ribonucleoproteins recognized by human antinuclear antibodies in retrovirus-infected cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

AUTO-ANTIBODIES TO CELL NUCLEI

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Mixed connective tissue disease: A clinicopathologic study of 20 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Immunochemical distinctions among histones and their variants in a solid-phase radioimmunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Antinuclear antibody induced by procainamide. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Procainamide-induced lupus erythematosus. Clinical and laboratory observations

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Kinetochore structure, duplication, and distribution in mammalian cells: analysis by human autoantibodies from scleroderma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Antiribonucleoprotein antibodies in connective tissue diseases: estimation by counterimmunoelectrophoresis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Circulating DNA:anti-DNA complexes in systemic lupus erythematosus. Detection and characterization by ultracentrifugation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

The immunofluorescent tumor imprint technique. II. The frequency of antinuclear factors in connective tissue diseases and dermatoses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Prospective study of immune response to hydralazine and development of antideoxyribonucleoprotein in patients receiving hydralazine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Antibodies to Epstein-Barr virus-determined antigens in normal subjects and in patients with seropositive rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Antibody to the rheumatoid arthritis nuclear antigen. Its relationship to in vivo Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

A DNA-reacting factor in serum of a patient with lupus erythematosus diffusus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Indirect Immunofluorescent Antinuclear Antibody Tests: Comparison of Sensitivity and Specificity of Different Substrates

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Direct evidence for circulating dna/anti-dna complexes in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Cell-mediated cytotoxicity to muscle in polymyositis. Effect of immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Antibodies to Double-stranded DNA: A Comparison of the Indirect Immunofluorescent Test Using Crithidia luciliae and the DNA-binding Assay

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Nonhistone nuclear antigens reactive with autoantibodies. Immunofluorescence studies on distribution in synchronized cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Experimental glomerulonephritis. The pathogenesis of a laboratory model resembling the spectrum of human glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Hydralazine-pyrimidine interactions may explain hydralazine-induced lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Presence of anti-Sm reactivity in autoimmune mouse strains

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

The interaction of lupus-inducing drugs with deoxyribonucleic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Granulocyte-specific antinuclear factors in serum and synovial fluid in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Site-specific cleavage by T1 RNase of U-1 RNA in u-1 ribonucleoprotein particles

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Antibodies to components of extractable nuclear antigen. Clinical characteristics of patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Seroepidemiological study of relationships between Epstein-Barr virus and rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

The incidence of Sjögren's sicca complex in a population of patients with keratoconjunctivitis sicca

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Autoantibodies directed against sicca syndrome antigens in the neonatal lupus syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Antibodies to Histones in Drug-Induced and Idiopathic Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

The CREST syndrome: a distinct serologic entity with anticentromere antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

A millipore filter assay for antibodies to native dna in sera of patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

The fine structure of the nucleolus during interphase and mitosis in Ehrlich tumour cells cultivated in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Experimental studies on the mechanism of induction of anti-nuclear antibodies by procainamide

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Histone reactivity of drug-induced antinuclear antibodies. A comparison of symptomatic and asymptomatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Intracellular distribution of low molecular weight RNA species in HeLa cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Immune Responses to Hydralazine and Nuclear Antigens in Hydralazine-Induced Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Certain Rheumatoid Factors React with both IgG and an Antigen Associated with Cell Nuclei

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Polyclonal human antibodies to IgG (rheumatoid factors) which cross-react with cell nuclei

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Certain rheumatoid factors react with nucleosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Nucleotide sequences of 4.5S RNAs associated with poly (A) -containing RNAs of mouse and hamster cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

DNA:Anti-DNA Complexes: Their Detection in Systemic Lupus Erythematosus Sera

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Blood factor in acute disseminated lupus erythematosus; determination of gamma globulin as specific plasma fraction

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Antigenic determinants on lysine-rich histones

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

A serum factor in lupus erythematosus with affinity for tissue nuclei

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

The reaction of the lupus erythematosus (L.E.) cell factor with deoxyribonucleoprotein of the cell nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Affinity between the lupus erythematosus serum factor and cell nuclei and nucleoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Micro-hemagglutination tests for detection of native and single-strand DNA antibodies and circulating DNA antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Microhemagglutination test for the detection of nucleoprotein antibody in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

1 reference

7 January 2021

A simple method of reducing the fading of immunofluorescence during microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Lymphotoxin formation by lymphocytes and muscle in polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Symptomatology and diagnosis in connective tissue disease. II. Evaluations and follow-up examinations in consequence of a speckled antinuclear immunofluorescence pattern

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Some functional properties of the RNP nucleoplasmic antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

On the Biochemical Nature of the 'Sm' Nucleoplasmic Antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Antibody to a soluble acidic nuclear antigen in Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Human Leukemia-Associated Anti-Nuclear Reactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Immunological studies concerning the nephritis of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Antibodies to polynucleotides in human sera: antigenic specificity and relation to disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Structure of Chromatin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

AUTOANTIBODIES AND DISEASE.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Identification of antibodies to nuclear acidic antigens by counterimmunoelectrophoresis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

The localization of in vivo bound complement in tissue section

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Antibodies to Nuclear Antigens in Patients Treated with Procainamide or Acetylprocainamide

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Pathogenesis of the glomerulonephritis of NZB/W mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Drug-induced systemic lupus erythematosus: A critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

1 reference

7 January 2021

Are snRNPs involved in splicing?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Two Novel Classes of Small Ribonucleoproteins Detected by Antibodies Associated with Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Mitogen and muscle extract induced in vitro proliferative responses in myasthenia gravis, dermatomyositis, and polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Huge knee effusion: a record?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

The pathologic effects of intravenously administered soluble antigen-antibody complexes. I. Passive serum sickness in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

1 reference

7 January 2021

Nuclear protein antigens in autoimmune rheumatic and connective tissue diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Anti-sDNA antibody purified from sera of human patients with systemic lupus erythematosus--i. Purification and characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Autoantibodies and the Spectrum of Sjögren's Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Heterogeneity of RNA protein antigens reactive with sera of patients with systemic lupus erythematosus. Description of a cytoplasmic nonribosomal antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Antibodies to DNA: False positive results?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Role of gamma globulins in pathogenesis of renal lesions in systemic lupus erythematosus and chronic membranous glomerulonephritis, with an observation on the lupus erythematosus cell reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

New serological methods for the detection of the L.E. factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Characterization of a high molecular weight acidic nuclear protein recognized by autoantibodies in sera from patients with polymyositis-scleroderma overlap

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Antibodies reacting with ribosomal ribonucleoprotein in connective tissue diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Nucleolar antigen specific for antinucleolar antibody in the sera of patients with systemic rheumatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Autoantibody to centromere (kinetochore) in scleroderma sera

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Distribution of kinetochore (centromere) antigen in mammalian cell nuclei

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Recent progress in the study of autoantibodies to nuclear antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Immunological Detection of Thymidine Photoproduct Formation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Experimental skin lesions in mice resembling systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Anti-RANA antibody: a marker for seronegative and seropositive rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Purification and characterization of a nuclear non-histone basic protein (Mi-1) which reacts with anti-immunoglobulin sera and the sera of patients with dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Profiles of antinuclear antibodies in systemic rheumatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Juvenile dermatomyositis: a clinical and immunologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Reaction of systemic lupus erythematosus antinative DNA antibodies with native DNA fragments from 20 to 1,200 base pairs

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Immunofluorescent localization of immunoglobulins, complement, and fibrinogen in human diseases. I. Systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Ribonucleoprotein (RNP) soluble nuclear antigen: Demonstration of its reaction with serum antibodies by counter-immunoelectrophoresis and further partial characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Measurement of Serum DNA-Binding Activity in Systemic Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Subsets in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Antibodies to cytoplasmic antigens in lupus erythematosus. Serologic marker for systemic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Immunoglobulin classes and IgG subclasses of human antinuclear antibodies. A correlation of complement fixation and the nephritis of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Quantitation and characterization of plasma DNA in normals and patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Correlation of a Precipitin Reaction to an RNA-Protein Antigen and a Low Prevalence of Nephritis in Patients with Systemic Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

DNA-binding property of Sm nuclear antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

On the Specificity of Antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Long-term T-cell-mediated immunity to Epstein-Barr virus in man. II. Components necessary for regression in virus-infected leukocyte cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

HLA-restricted T-cell recognition of Epstein–Barr virus-infected B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Antinucleolar antibodies. Their frequency and diagnostic association

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Complement fixation with cell nuclei and DNA in lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Relationship between Deoxyribonucleoprotein and Deoxyribonucleic Acid Antibodies in Systemic Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Enzyme-linked immunosorbent assay in the study of histone antigens and nucleosome structure

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Serum antinuclear antibodies in progressive systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Deoxyribonucleic acid strandedness. Partial characterization of the antigenic regions binding antibodies in lupus erythematosus serum

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Immunologic factors and clinical activity in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Anti-SS-A antibody and other antinuclear antibodies in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Association of autoantibodies to different nuclear antigens with clinical patterns of rheumatic disease and responsiveness to therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA)

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Association of Antibodies to Ribonucleoprotein and Sm Antigens with Mixed Connective-Tissue Disease, Systemic Lupus Erythematosus and Other Rheumatic Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

In vitro effects of Epstein-Barr virus on peripheral blood mononuclear cells from patients with rheumatoid arthritis and normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

An appraisal of tests for native DNA antibodies in connective tissue diseases. Clinical usefulness of Crithidia luciliae assay

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Remission of Procainamide-Induced Lupus Erythematosus with N-Acetylprocainamide Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Antinuclear reactivity of sera in patients with leukemia and other neoplastic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Detection of anti-DNA antibody using synthetic antigens. Characterization and clinical significance of binding of poly (deoxyadenylate-deoxythymidylate) by serum

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Binding of synthetic double-stranded DNA by serum from patients with systemic lupus erythematosus: correlation with renal histology

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Circulating antibodies in polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Double-Helical Polynucleotides: Immunochemical Recognition of Differing Conformations

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Reactions of systemic lupus erythematosus sera with histone fractions and histone-DNA complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Antibodies to denatured deoxyribonucleic acid in lupus erythematosus serum. IV. Evidence for purine determinants in DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Secondary structure in denatured DNA is responsible for its reaction with antinative DNA antibodies of systemic lupus erythematosus sera

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

The antigenic determinants of denatured DNA reactive with lupus erythematosus serum

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Molecular relationships between two nuclear antigens, ribonucleoprotein and Sm: purification of active antigens and their biochemical characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

A nuclear antigen associated with cell proliferation and blast transformation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

An Immunologic Precipitin System between Soluble Nucleoprotein and Serum Antibody in Systemic Lupus Erythematosus*

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Immunopathology and pathogenesis of cutaneous involvement in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

An immunofluorescent study of the skin lesions in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Studies on Antibodies to Histones by Immunofluorescence

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Anti-tissue antibodies in rheumatic disease: standardization and nomenclature

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Purification and characterization of a nuclear SS-B antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Distribution of Antibodies to Native DNA, Single-Stranded DNA, and Double-Stranded RNA in Mouse Serums

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Defective EBV-specific suppressor T-cell function in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Cutaneous Immunopathology: Recent Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Experimental glomerulonephritis: immunological events and pathogenetic mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Antibodies to nuclear antigens in polymyositis: relationship to autoimmune 'overlap syndromes' and carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Nuclear antigens: characterization of the acidic nuclear ribonucleoprotein-Sm-antigen complex by analytical and preparative isoelectric focusing

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Small molecular weight monodisperse nuclear RNA

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

A clinical study of serum antinuclear factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Vascular Deposits of Immunoglobulin and Complement in Idiopathic Inflammatory Myopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Identification of the immunogenically active components of the Sm and RNP antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Antinuclear antibody response to procainamide in man and laboratory animals

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Granulocyte-specific antinuclear factors in synovial fluids and sera from patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Anti-DNA antibody in procainmide-induced lupus erythematosus. Determination using DNA fractionated by methylated albumin-kieselguhr chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Specific concentration of polynucleotide immune complexes in the cryoprecipitates of patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Development of antibodies to ribonucleoprotein following short-term therapy with procainamide

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. Association of high avidity antinative DNA antibody with glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Identification of a clinical subset of systemic lupus erythematosus by antibodies to the sm antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Deoxyribonucleic acid antibody: a method to detect its primary interaction with deoxyribonucleic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Antinuclear antibody with distinct specificity for polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

A small nuclear ribonucleoprotein is required for splicing of adenoviral early RNA sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Genetics, hypersensitivity and the connective tissue diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960836-6

7 January 2021

Mayo Clinic Proceedings

4

44

664

Alarcon-Segovia

1969

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60836-6

Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis

22 August 2023

series ordinal

34

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60836-6

22 August 2023

Mayo Clinic Proceedings

92

23

25

Hargraves

1948

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60836-6

Observations on the in vivo reaction of antinuclear antibodies with epidermal cells

22 August 2023

series ordinal

107

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60836-6

Immunoreactivity to Nuclear Antigens in Systemic Lupus Erythematosus with or without Nephritis, and in Other Connective Tissue Diseases, with Particular Reference to the RNA-Protein Antigen

22 August 2023

series ordinal

168

1 reference

https://api.crossref.org/works/10.1016/S0065-2776(08)60836-6

22 August 2023

Identifiers

0 references

1 reference